About us - Newsroom - Media releases

Media releases

View 10 | 50 | 100 entries/page
Showing 1 - 9 of 9

Natural Killer Cells: Cultivation, Activation and Growth

Miltenyi Biotec extends its product portfolio in the area of cell culture media with the NK MACS® Medium


August 4, 2017

Miltenyi Biotec named as an employer for the future

In its current issue, the news magazine “Focus” has published the results of a survey with the title “Germany’s best jobs with a future“.


July 3, 2017

New: MACSprep PBMC Isolation Kit, human from Miltenyi Biotec

Fast and convenient isolation of untouched PBMCs


June 14, 2017

New: MACS® GMP T Cell TransAct™ from Miltenyi Biotec

MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade.


April 20, 2017

The EU-funded project CARAT offers fellowships for a training course on CAR T cell manufacturing

The EU project CARAT has taken on the mission to deliver new tools and technologies to enable the wide use of novel personalized cancer treatment options. In 2017, CARAT will grant five scientists with a fellowship that gives them the opportunity to participate in a unique training.


January 24, 2017

Reliable and reproducible flow cytometry results

Miltenyi Biotec introduces the largest portfolio of recombinant antibodies optimized for flow cytometry – REAfinity™ Antibodies


December 8, 2016

The course schedule has arrived! MACS® Academy is starting its new program

Once again, the MACS® Academy is offering a comprehensive course program at its locations in Bergisch Gladbach, Germany and San Diego, USA, in 2017 - miltenyibiotec.com/macsacademy.
November 22, 2016

Miltenyi Biotec acquires exclusive rights for the distribution and development of the viral transduction enhancer Vectofusin-1® from Genethon

Genethon, a leader in the field of gene therapy treatments for rare diseases, and Miltenyi Biotec, a global front-runner in cell processing and related technologies in cell therapy, have announced the execution of an exclusive license to the patents and trademarks for the development and commercialization of Vectofusin-1® by Miltenyi Biotec.
September 29, 2016

CE marked MACS® IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485

Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research.
September 19, 2016

View 10 | 50 | 100 entries/page
Showing 1 - 9 of 9

Customer login

Go

Forgot password?
Register for account

0 Shopping cart

Contact

Miltenyi Biotec Inc.
Phone: +1 800 FOR MACS
Fax:+1 877 591 1060
macs@miltenyibiotec.com
Contact overview

Product finder

Antibody panel builder

Toolbox

Loading...
Media contact

Media contact

Change country

Please select your country to continue